The EIC Cell and Gene Therapy Portfolio has released its 2024 Activity Report, highlighting key advancements and collaborative efforts in this rapidly evolving field. Launched in 2021 by the European Innovation Council (EIC), the portfolio supports European research and innovation in cell and gene therapy, addressing challenges in development, manufacturing, and commercialization.
The report covers activities up to December 31, 2024, featuring contributions from nine projects, among which T-FITNESS. The portfolio was overseen by Iordanis Arzimanoglou (2022–May 2024) and Orsolya Symmons (from September 2024).
Read the full report here.
Comments are closed.